Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $1.86 billion. The enterprise value is $1.52 billion.
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 42.01 million shares outstanding. The number of shares has increased by 22.50% in one year.
| Current Share Class | 42.01M |
| Shares Outstanding | 42.01M |
| Shares Change (YoY) | +22.50% |
| Shares Change (QoQ) | +2.03% |
| Owned by Insiders (%) | 7.96% |
| Owned by Institutions (%) | 83.41% |
| Float | 32.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.40 |
| Forward PS | 4.59 |
| PB Ratio | 5.49 |
| P/TBV Ratio | 5.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.57, with a Debt / Equity ratio of 0.21.
| Current Ratio | 5.57 |
| Quick Ratio | 5.47 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.02 |
Financial Efficiency
Return on equity (ROE) is -33.98% and return on invested capital (ROIC) is -18.90%.
| Return on Equity (ROE) | -33.98% |
| Return on Assets (ROA) | -16.05% |
| Return on Invested Capital (ROIC) | -18.90% |
| Return on Capital Employed (ROCE) | -26.34% |
| Revenue Per Employee | $723,449 |
| Profits Per Employee | -$324,901 |
| Employee Count | 323 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 21.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.46% in the last 52 weeks. The beta is 0.94, so TARS's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +19.46% |
| 50-Day Moving Average | 48.10 |
| 200-Day Moving Average | 42.96 |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | 665,105 |
Short Selling Information
The latest short interest is 8.31 million, so 19.78% of the outstanding shares have been sold short.
| Short Interest | 8.31M |
| Short Previous Month | 8.38M |
| Short % of Shares Out | 19.78% |
| Short % of Float | 25.31% |
| Short Ratio (days to cover) | 12.16 |
Income Statement
In the last 12 months, TARS had revenue of $233.67 million and -$104.94 million in losses. Loss per share was -$2.72.
| Revenue | 233.67M |
| Gross Profit | 161.56M |
| Operating Income | -109.17M |
| Pretax Income | -150.07M |
| Net Income | -104.94M |
| EBITDA | -107.75M |
| EBIT | -109.17M |
| Loss Per Share | -$2.72 |
Full Income StatementBalance Sheet
The company has $407.92 million in cash and $72.37 million in debt, giving a net cash position of $335.55 million or $7.99 per share.
| Cash & Cash Equivalents | 407.92M |
| Total Debt | 72.37M |
| Net Cash | 335.55M |
| Net Cash Per Share | $7.99 |
| Equity (Book Value) | 342.46M |
| Book Value Per Share | 8.15 |
| Working Capital | 394.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$65.89 million and capital expenditures -$1.98 million, giving a free cash flow of -$67.87 million.
| Operating Cash Flow | -65.89M |
| Capital Expenditures | -1.98M |
| Free Cash Flow | -67.87M |
| FCF Per Share | -$1.62 |
Full Cash Flow StatementMargins
Gross margin is 69.14%, with operating and profit margins of -46.72% and -44.91%.
| Gross Margin | 69.14% |
| Operating Margin | -46.72% |
| Pretax Margin | -44.91% |
| Profit Margin | -44.91% |
| EBITDA Margin | -46.11% |
| EBIT Margin | -46.72% |
| FCF Margin | n/a |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.50% |
| Shareholder Yield | -22.50% |
| Earnings Yield | -5.65% |
| FCF Yield | -3.65% |
Analyst Forecast
The average price target for TARS is $66.33, which is 50.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $66.33 |
| Price Target Difference | 50.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 40.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 5.27 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.27 |
| Piotroski F-Score | 3 |